2017-2022 United States Prostate Cancer Diagnostics Market Report (Status and Outlook)

September 2017 | 110 pages | ID: 2B78A6A8087EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Prostate Cancer Diagnostics market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In United States market, the top players include

• Genomic Health
• Abbott
• OPKO
• Siemens Healthcare
• DiaSorin
• bioMeriux
• Roche
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry Genetics

This report with sales, revenue and market share for each type, split by product types/category, covering

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

This report focuses on sales, market share and growth rate of Prostate Cancer Diagnostics in each application, split by applications/end use industries, covers

• < 55
• 55-75
• > 75

Contents

1 PROSTATE CANCER DIAGNOSTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Diagnostics
1.2 Prostate Cancer Diagnostics Market Segment by Types
  1.2.1 United States Prostate Cancer Diagnostics Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Prostate Cancer Diagnostics Sales Market Share by Types in 2016
  1.2.3 Tumor Biomarker Tests
  1.2.4 Imaging
  1.2.5 Biopsy
Other
1.3 United States Prostate Cancer Diagnostics Market Segment by Applications/End Use Industries
  1.3.1 United States Prostate Cancer Diagnostics Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Prostate Cancer Diagnostics Sales Market Share by Applications/End Industrials in 2016
  1.3.3 <
  1.3.4 55-75
>
1.4 United States Prostate Cancer Diagnostics Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Prostate Cancer Diagnostics Overview
  1.4.2 United States Prostate Cancer Diagnostics Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES PROSTATE CANCER DIAGNOSTICS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS/MANUFACTURERS

2.1 United States Prostate Cancer Diagnostics Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Vendors (2012-2017)
2.3 United States Prostate Cancer Diagnostics Average Price by Vendors in 2016
2.4 United States Prostate Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends
  2.5.1 Prostate Cancer Diagnostics Market Concentration Rate
  2.5.2 Prostate Cancer Diagnostics Market Share of Top 3 and Top 5 Vendors
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PROSTATE CANCER DIAGNOSTICS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Prostate Cancer Diagnostics Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
  3.1.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Prostate Cancer Diagnostics Price by Type (2012-2017)
3.2 United States Prostate Cancer Diagnostics Sales and Market Share by Application (2012-2017)
3.3 United States Market Prostate Cancer Diagnostics Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES PROSTATE CANCER DIAGNOSTICS VENDORS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Genomic Health
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Abbott
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
4.3 OPKO
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Siemens Healthcare
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
4.5 DiaSorin
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
4.6 bioMeriux
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Roche
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
4.8 MDx Health
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Beckman Coulter
  4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.9.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    9.9.2.1 Type
    9.9.2.2 Type
  4.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.9.4 Main Business/Business Overview
4.10 Myriad Genetics
  4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.10.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.10.2.1 Type
    4.10.2.2 Type
  4.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.10.4 Main Business/Business Overview
4.11 Ambry Genetics
  4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.11.2 Prostate Cancer Diagnostics Product Types, Application and Specification
    4.11.2.1 Type
    4.11.2.2 Type
  4.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  4.11.4 Main Business/Business Overview

5 PRODUCTION COST ANALYSIS OF PROSTATE CANCER DIAGNOSTICS

5.1 Main Raw Materials of Prostate Cancer Diagnostics
  5.1.1 List of Prostate Cancer Diagnostics Main Raw Materials
  5.1.2 Prostate Cancer Diagnostics Main Raw Materials Price Analysis
  5.1.3 Prostate Cancer Diagnostics Raw Materials Major Suppliers
  5.1.4 Prostate Cancer Diagnostics Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of Prostate Cancer Diagnostics
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Production Expenses
5.3 Prostate Cancer Diagnostics Manufacturing Process/Method

6 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

6.1 Prostate Cancer Diagnostics Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Vendors in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Sales Channel
  7.1.1 Direct Sales
  7.1.2 Indirect Sales
  7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Prostate Cancer Diagnostics Distributors/Traders List in United States

8 MARKET INFLUENCES FACTORS ANALYSIS

8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation

9 UNITED STATES PROSTATE CANCER DIAGNOSTICS MARKET FORECAST (2017-2022)

9.1 United States Prostate Cancer Diagnostics Sales, Revenue and Price Forecast (2017-2022)
  9.1.1 United States Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2017-2022)
  9.1.2 United States Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
  9.1.3 United States Prostate Cancer Diagnostics Price Trend Forecast (2017-2022)
9.2 United States Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
9.3 United States Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Diagnostics
Table Product Specifications of Prostate Cancer Diagnostics
Figure United States Prostate Cancer Diagnostics Sales (volume) for Each Type (2012-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Types in 2016
Table Types of Prostate Cancer Diagnostics
Figure Product Picture of Tumor Biomarker Tests
Table Major Players of Tumor Biomarker Tests
Figure Product Picture of Imaging
Table Major Players of Imaging
Figure Product Picture of Biopsy
Table Major Players of Biopsy
Figure Product Picture of Other
Table Major Players of Other
Figure United States Prostate Cancer Diagnostics Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Applications/End Industrials in 2016
Table Applications of Prostate Cancer Diagnostics
Figure < 55 Examples
Figure 55-75 Examples
Figure > 75 Examples
Figure United States Prostate Cancer Diagnostics Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Prostate Cancer Diagnostics Sales (Volume) Status and Forecast (2012-2022)
Table United States Prostate Cancer Diagnostics Sales by Vendors (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Market Share (%) by Vendors (2012-2017)
Figure United States Prostate Cancer Diagnostics Sales Share by Vendors in 2016
Figure United States Prostate Cancer Diagnostics Sales Share by Vendors in 2017
Table United States Prostate Cancer Diagnostics Revenue (Million USD) by Vendors (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue Market Share (%) by Vendors (2012-2017)
Figure United States Prostate Cancer Diagnostics Revenue Share by Vendors in 2016
Figure United States Prostate Cancer Diagnostics Revenue Share by Vendors in 2017
Figure United States Prostate Cancer Diagnostics Average Price by Vendors in 2016
Table United States Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors Prostate Cancer Diagnostics Product Types
Figure Prostate Cancer Diagnostics Market Share of Top 3 Vendors
Figure Prostate Cancer Diagnostics Market Share of Top 5 Vendors
Table United States Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Type 2016
Figure 2016 United States Prostate Cancer Diagnostics Sales Market Share by Type
Table United States Prostate Cancer Diagnostics Revenue (Million USD) by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Revenue Market Share by Type (2012-2017)
Figure United States Prostate Cancer Diagnostics Revenue Market Share by Type 2016
Figure 2016 United States Prostate Cancer Diagnostics Revenue Market Share by Type
Table United States Prostate Cancer Diagnostics Price by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table United States Prostate Cancer Diagnostics Sales and Market Share by Application (2012-2017)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure 2016 United States Prostate Cancer Diagnostics Sales Market Share by Application
Table United States Market Prostate Cancer Diagnostics Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Genomic Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genomic Health Prostate Cancer Diagnostics Market Share (2012-2017)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Prostate Cancer Diagnostics Market Share (2012-2017)
Table OPKO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OPKO Prostate Cancer Diagnostics Market Share (2012-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Siemens Healthcare Prostate Cancer Diagnostics Market Share (2012-2017)
Table DiaSorin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure DiaSorin Prostate Cancer Diagnostics Market Share (2012-2017)
Table bioMeriux Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure bioMeriux Prostate Cancer Diagnostics Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Prostate Cancer Diagnostics Market Share (2012-2017)
Table MDx Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MDx Health Prostate Cancer Diagnostics Market Share (2012-2017)
Table Beckman Coulter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Beckman Coulter Prostate Cancer Diagnostics Market Share (2012-2017)
Table Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Myriad Genetics Prostate Cancer Diagnostics Market Share (2012-2017)
Table Ambry Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ambry Genetics Prostate Cancer Diagnostics Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Prostate Cancer Diagnostics Main Raw Materials Price Trend
Table Prostate Cancer Diagnostics Raw Materials Major Suppliers List
Figure Production Cost Structure of Prostate Cancer Diagnostics
Figure Prostate Cancer Diagnostics Manufacturing Process/Method
Figure Prostate Cancer Diagnostics Value Chain Analysis
Table Raw Materials Sources of Prostate Cancer Diagnostics Major Vendors in 2016
Table Major Buyers of Prostate Cancer Diagnostics
Table Prostate Cancer Diagnostics Distributors/Traders List in United States
Figure United States Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2017-2022)
Figure United States Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
Figure United States Prostate Cancer Diagnostics Price Trend Forecast (2017-2022)
Table United States Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2017-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share Forecast by Type in 2022
Table United States Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share Forecast by Application (2017-2022)
Figure United States Prostate Cancer Diagnostics Sales Market Share Forecast by Application in 2022